Revised SPCs: OxyContin (oxycodone) prolonged release tablets

Various changes include updated warnings regarding concomitant use with benzodiazepines, addition of a warning regarding use of MAOIs within the previous 2 weeks, and the addition of sleep apnoea syndrome as a possible side effect.

electronic Medicines compendium